The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification
Abstract
Aims: We sought to evaluate the outcomes of transcatheter mitral valve replacement (TMVR) for patients with degenerated bioprostheses [valve-in-valve (ViV)], failed annuloplasty rings [valve-in-ring (ViR)], and severe mitral annular calcification [valve-in-mitral annular calcification (ViMAC)]. Methods and results: From the TMVR multicentre registry, procedural and clinical outcomes of ViV, ViR, and ViMAC were compared according to Mitral Valve Academic Research Consortium (MVARC) criteria. A total of 521 patients with mean Society of Thoracic Surgeons score of 9.0 ± 7.0% underwent TMVR (322 patients with ViV, 141 with ViR, and 58 with ViMAC). Trans-septal access and the Sapien valves were used in 39.5% and 90.0%, respectively. Overall technical success was excellent at 87.1%. However, left ventricular outflow tract obstruction occurred more frequently after ViMAC compared with ViR and ViV (39.7% vs. 5.0% vs. 2.2%; P < 0.001), whereas second valve implantation was more frequent in ViR compared with ViMAC and ViV (12.1% vs. 5.2% vs. 2.5%; P < 0.001). Accordingly, technical success rate was higher after ViV compared with ViR and ViMAC (94.4% vs. 80.9% vs. 62.1%; P < 0.001). Compared with ViMAC and ViV groups, ViR group had more frequent post-procedural mitral regurgitation ≥moderate (18.4% vs. 13.8% vs. 5.6%; P < 0.001) and subsequent paravalvular leak closure (7.8% vs. 0.0% vs. 2.2%; P = 0.006). All-cause mortality was higher after ViMAC compared with ViR and ViV at 30 days (34.5% vs. 9.9% vs. 6.2%; log-rank P < 0.001) and 1 year (62.8% vs. 30.6% vs. 14.0%; log-rank P < 0.001). On multivariable analysis, patients with failed annuloplasty rings and severe MAC were at increased risk of mortality after TMVR [ViR vs. ViV, hazard ratio (HR) 1.99, 95% confidence interval (CI) 1.27-3.12; P = 0.003; ViMAC vs. ViV, HR 5.29, 95% CI 3.29-8.51; P < 0.001]. Conclusion: The TMVR provided excellent outcomes for patients with degenerated bioprostheses despite high surgical risk. However, ViR and ViMAC were associated with higher rates of adverse events and mid-term mortality compared with ViV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Burden of valvular heart diseases: a population-based study
Nkomo, V. T., Gardin, J. M., Skelton, T. N., Gottdiener, J. S., Scott, C. G., & Enriquez-Sarano, M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69208-8 · Cited by 4,881
Webb, J. G., Pasupati, S., Humphries, K., Thompson, C., Altwegg, L., Moss, R., Sinhal, A., Carere, R. G., Munt, B., Ricci, D., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.698258 · Cited by 1,016
Self-citationTwo-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation
Goldstein, D., Moskowitz, A. J., Gelijns, A. C., Ailawadi, G., Parides, M. K., Perrault, L. P., Hung, J. W., Voisine, P., Dagenais, F., Gillinov, A. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1512913 · Cited by 972
Mechanical or Biologic Prostheses for Aortic-Valve and Mitral-Valve Replacement
Goldstone, A. B., Chiu, P., Baiocchi, M., Lingala, B., Patrick, W. L., Fischbein, M. P., & Woo, Y. J. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1613792 · Cited by 691
Prosthetic Heart Valve Thrombosis
Dangas, G. D., Weitz, J. I., Giustino, G., Makkar, R., & Mehran, R. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.958 · Cited by 502
Self-citationTwo-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation
Michler, R. E., Smith, P. K., Parides, M. K., Ailawadi, G., Thourani, V., Moskowitz, A. J., Acker, M. A., Hung, J. W., Chang, H. L., Perrault, L. P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602003 · Cited by 490
Outcomes With Transcatheter Mitral Valve Repair in the United States
Sorajja, P., Vemulapalli, S., Feldman, T., Mack, M., Holmes, D. R., Stebbins, A., Kar, S., Thourani, V., & Ailawadi, G. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.015 · Cited by 444
Self-citationGuerrero, M., Urena, M., Himbert, D., Wang, D. D., Eleid, M., Kodali, S., George, I., Chakravarty, T., Mathur, M., Holzhey, D., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.054 · Cited by 364
Self-citationZahn, E. M., Hellenbrand, W. E., Lock, J. E., & McElhinney, D. B. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.06.034 · Cited by 322
Effect of Recurrent Mitral Regurgitation Following Degenerative Mitral Valve Repair
Suri, R. M., Clavel, M.-A., Schaff, H. V., Michelena, H. I., Huebner, M., Nishimura, R. A., & Enriquez-Sarano, M. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.098 · Cited by 269
Cited by
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab395 · Cited by 5,685
Self-citationThe Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
Vogel, B., Acevedo, M., Appelman, Y., Bairey Merz, C. N., Chieffo, A., Figtree, G. A., Guerrero, M., Kunadian, V., Lam, C. S. P., Maas, A. H. E. M., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00684-x · Cited by 1,488
2025 ESC/EACTS Guidelines for the management of valvular heart disease
Praz, F., Borger, M. A., Lanz, J., Marin-Cuartas, M., Abreu, A., Adamo, M., Ajmone Marsan, N., Barili, F., Bonaros, N., Cosyns, B., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf194 · Cited by 1,072
Self-citation2021 ESC/EACTS Guidelines for the management of valvular heart disease
Beyersdorf, F., Vahanian, A., Milojevic, M., Praz, F., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2021) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezab389 · Cited by 622
Self-citationVahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2022) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2022.05.006 · Cited by 527
Self-citation
Metadata
- Authors
- Yoon, S.-H., Whisenant, B. K., Bleiziffer, S., Delgado, V., Dhoble, A., Schofer, N., Eschenbach, L., Bansal, E., Murdoch, D. J., Ancona, M., Schmidt, T., Yzeiraj, E., Vincent, F., Niikura, H., Kim, W.-K., Asami, M., Unbehaun, A., Hirji, S., Fujita, B., Silaschi, M., Tang, G. H. L., Kuwata, S., Wong, S. C., Frangieh, A. H., Barker, C. M., Davies, J. E., Lauten, A., Deuschl, F., Nombela-Franco, L., Rampat, R., Nicz, P. F. G., Masson, J.-B., Wijeysundera, H. C., Sievert, H., Blackman, D. J., Gutierrez-Ibanes, E., Sugiyama, D., Chakravarty, T., Hildick-Smith, D., de Brito, F. S., Jensen, C., Jung, C., Smalling, R. W., Arnold, M., Redwood, S., Kasel, A. M., Maisano, F., Treede, H., Ensminger, S. M., Kar, S., Kaneko, T., Pilgrim, T., Sorajja, P., Van Belle, E., Prendergast, B. D., Bapat, V., Modine, T., Schofer, J., Frerker, C., Kempfert, J., Attizzani, G. F., Latib, A., Schaefer, U., Webb, J. G., Bax, J. J., & Makkar, R. R.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-10-23
- Volume
- 40
- Issue
- 5
- Pages
- 441-451
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2898581089
- Cited by
- 383
- References
- 22
- FWCI
- 30.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. https://app.cochat.ai/papers/10.1093/eurheartj/ehy590
- The paper
- Yoon, S.-H., Whisenant, B. K., Bleiziffer, S., Delgado, V., Dhoble, A., Schofer, N., Eschenbach, L., Bansal, E., Murdoch, D. J., Ancona, M., Schmidt, T., Yzeiraj, E., Vincent, F., Niikura, H., Kim, W.-K., Asami, M., Unbehaun, A., Hirji, S., Fujita, B., . . . Makkar, R. R. (2019). Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. European Heart Journal. https://doi.org/10.1093/eurheartj/ehy590
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.